2016 Inductees

William S. Dalton

2016 Inductees

William S. Dalton

William S. Dalton, Ph.D., M.D.,

Founder and CEO of M2Gen®

10 U.S. patents

William Dalton, former president and CEO of Moffitt Cancer Center & Research Institute, is the founder and current CEO of M2Gen®, a subsidiary of Moffitt, recognized for his revolutionizing developments in cancer treatment. His research in molecular mechanisms of drug resistance led to the creation of Total Cancer Care™: personalized protocols for the treatment of cancer and information/decision tools used by clinicians worldwide. To date, Total Cancer Care™ has impacted the lives of over 120,000 patients and includes one of the largest bio-repositories and data warehouses in the U.S., dedicated to the improvement of personalized medicine.

Dalton holds 10 U.S. patents and is regarded as a health policy expert on the study and development of the most effective approaches to cancer research and serves at the state level in an advisory role to the Governor, the Chief Justice, and Legislature, to promote the economic growth of Florida and improve the quality of life of the citizens of Florida.

D. Yogi Goswami

2016 Inductees

D. Yogi Goswami

D. Yogi Goswami, Ph.D.

Distinguished University Professor in Chemical Engineering
Director of the Clean Energy Research Center
University of South Florida

19 U.S. patents

Yogi Goswami is a Distinguished University Professor in chemical engineering, and director of the Clean Energy Research Center, at the University of South Florida, known for his pioneering contributions and technology development related to solar energy and indoor air quality. Goswami’s contributions in combined power/cooling cycles have impacted global research in a new class of thermodynamic cycles. He has invented nano-scale antenna technologies to convert sunlight to power and thermal energy storage technologies. He also founded Molekule (formerly Transformair, Inc.), which is commercializing his technology to destroy indoor air pollutants including viruses, bacteria, mold, airborne fumes and allergens, which is helping allergy and asthma sufferers worldwide. The Molekule air purifier has been named one of Time Magazine’s 25 Best Inventions of 2017 for its ability to not just trap harmful pollutants but eliminate them.

Goswami holds 19 U.S. patents and has served as an advisor and given testimonies on energy policy and the transition to renewable energy to the U.S. Congress and various Governments around the world. He has published 19 books and is the Editor-in-Chief of Solar Energy journal.

Alan Marshall

2016 Inductees

Alan George Marshall

Alan George Marshall, Ph.D.

Professor of Chemistry
Founding Director and Chief Scientist of the Ion Cyclotron Resonance (ICR) Program
Florida State University

9 U.S. patents

Alan Marshall is a professor of chemistry and founding director and chief scientist of the Ion Cyclotron Resonance (ICR) Program at Florida State University, which has attracted $50M in grant support to Florida. He co-invented and leads continuing development of the Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass spectrometry, which aids in the study of molecular structure and the composition of cells.

Marshall holds 8 U.S. patents and his inventions created an entirely new arena of discovery in a broad range of fields, from petroleum analysis to biomedicine. His original patents spawned the first commercial instrument (Nicolet Instrument Corp.) and subsequent FT-ICR instruments from other companies, with more than 800 FT-ICR instruments installed worldwide.

Nicholas Muzyczka

2016 Inductees

Nicholas Muzyczka

Nicholas Muzyczka, Ph.D.

Professor of Microbiology
Edward R. Koger Eminent Scholar for Cancer Research
University of Florida

16 U.S. patents

Nicholas Muzyczka is a professor of microbiology and Edward R. Koger Eminent Scholar for Cancer Research at the University of Florida, recognized for his pivotal invention of the “granddaddy patent” for recombinant adeno associated virus (rAAV) vectors. Muzyczka’s lab created a breakthrough with successful DNA replication of the AAV2 genome.

He holds 15 U.S. patents and his research has led to potential therapies for neurodegenerative, pulmonary, cardiovascular, and eye diseases. In 1994 he became founding director of Powell Gene Therapy Center, making UF one of the leading institutions in AAV gene therapy. In 2001, Muzyczka founded Applied Genetic Technologies Corp (AGTC) a Florida based company that commercializes gene therapy applications.

Jacqueline Quinn

2016 Inductees

Jacqueline W. Quinn

Jacqueline W. Quinn, Ph.D.

Environmental Engineer
Research Scientist
Project Manager for Regolith & Environment Science and Oxygen Lunar Volatiles Extraction (RESOLVE)
NASA Kennedy Space Center

12 U.S. patents

Jacqueline Quinn is a NASA environmental engineer who leads diverse environmental chemistry research at the Kennedy Space Center and invented NASA’s most licensed and recognized technology for groundwater remediation, Emulsified Zero Valent Iron (EZVI). Additional environmental remediation methods created by Quinn include AMTS and SPEARS, used for removal of cancer-causing PCBs (polychlorinated biphenyls) in materials, soils and sediments.

Quinn holds 12 U.S. patents and her technologies have been licensed by companies throughout the United States and internationally. In 2005, she received both NASA’s Commercial and Government Invention of the Year awards. Quinn received the Federal Lab Consortium’s Award for Excellence in Technology Transfer in 2006 and was inducted into the Space Technology Hall of Fame in 2007. In 2018 she was elected to the National Inventors Hall of Fame.

Andrew V. Schally

2016 Inductees

Andrew Schally

Andrew V. Schally, Ph.D, MDhc (Multi), D.Sc,hc.

1977 Nobel Prize in Physiology or Medicine
Distinguished Medical Research Scientist
Department of Veterans Affairs
Distinguished Professor of Pathology
University of Miami
Chief of the Miami Veterans Affairs Medical Center Endocrine, Polypeptide and Cancer Institute

36 U.S. patents

Andrew Schally, Nobel Laureate and Distinguished Medical Research Scientist at the Department of Veterans Affairs, Distinguished Professor of pathology at the University of Miami, and chief of the Miami Veterans Affairs Medical Center Endocrine, Polypeptide and Cancer Institute. Schally received the 1977 Nobel Prize in Physiology or Medicine and was elected to the National Academy of Sciences in 1978 for his discovery of hypothalamic hormones. Subsequently he pioneered the application of analogues of hypothalamic hormones to cancer treatment, including the therapy of prostate cancer with agonists of LHRH used worldwide.

Schally holds 32 U.S. patents licensed to 5 companies and is author or co-author of more than 2,400 publications.

M.J. Soileau

2016 Inductees

M.J. Soileau

M.J. Soileau, Ph.D.

University Distinguished Professor of Optics and photonics, Electrical and Computer Engineering, and Physics
University of Central Florida

6 U.S. patents

From 1998 until 2016, M.J. Soileau led the University of Central Florida’s (UCF) sponsored research activities. He is known for his pioneering research in nonlinear interaction of laser pulses with optical materials and for leading the development of the internationally recognized Center for Research and Education in Optics and Lasers (CREOL) at UCF.

Soileau holds 6 U.S. patents, the applications of which have contributed to the advancement of high energy laser optics used by the United States Department of Defense. His expertise is sought by high technology corporations in the areas of photonics and lasers, and by legal firms in the area of patents. His leadership has helped UCF become a catalyst for the region’s high-tech development, stimulating the local economy in central Florida.